Is Regeneron Pharmaceuticals (REGN) A Great Pick for Value Investors?Zacks Investment Research • 08/14/19
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/06/19
Regeneron's Blockbuster New Launches And Innovative Pipeline Will Outweigh Eylea Biosimilar CompetitionSeeking Alpha • 07/15/19
4 Medical Stocks to Consider After Federal Judge Blocks Trump ProposalZacks Investment Research • 07/11/19
Regeneron And Sanofi Tried To Outperform Themselves — And Couldn'tInvestors Business Daily • 06/21/19